Skip to content

Three Anaesthesic Method in Electroconvulsive Theraphy

Sevoflurane Alone and Propofol With or Without Remifentanil in Electroconvulsive Therapy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01759589
Enrollment
39
Registered
2013-01-03
Start date
2011-01-31
Completion date
2011-08-31
Last updated
2013-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

electroconvulsive therapy,sevoflurane,propofol,remifentanil

Brief summary

To compare the effectiveness of three different anesthetic regimens (propofol, remifentanil-propofol and sevoflurane in ECT.

Detailed description

The purpose of this study is to compare the effectiveness of three different anesthetic regimens (propofol, remifentanil-propofol and sevoflurane) with respect to seizure duration, postictal suppression index, early and midictal amplitude, hemodynamic variables and recovery profiles in ECT.

Interventions

DRUGPropofol

1 mg/kg propofol IV (over 15 sec) during anesthesia induction

1 µg/kg IV (over 60 sec)remifentanil and 0.5 mg/kg propofol IV (over 15 sec)during anesthesia induction

DRUGSevoflurane

Sevoflurane was started at 6% for induction and continued at 1% until the electrical stimulus was delivered

Sponsors

Inonu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Upremedicated ASA I-II (American Society of Anesthesiologists's physical status) patients, * Patients scheduled for six ECT sessions for a variety of psychiatric conditions (major depression, schizophrenia)

Exclusion criteria

* Involuntary patient status * Patients with known or self-declared needle or mask phobia * Pregnancy * Asthma * Cerebrovascular disease, * History of myocardial infarction in the previous 6 months, * Atrial fibrillation or flutter,heart block, * A known or family history of reactions to the study drugs.

Design outcomes

Primary

MeasureTime frameDescription
Seizure durationThe patients were observed about seizure up to ten minutes after electrical stimulationAfter anesthesia induction patients were administered electrical stimulation and seizure duration were measured.

Secondary

MeasureTime frameDescription
postictal suppression indexcompleting seizure in one hourAfter anesthesia induction, patients were administered electrical stimulation. Then, postictal suppression index, a parameter that shows seizure quality, was determined from seizure records.
Recovery parameters (spontaneous breathing, eye opening, and obeying of verbal commands)after seizure in one hour in operation room.The time from the end of succinylcholine administration to the recovery of spontaneous breathing, eye opening, and obeying of verbal commands were recorded.
Hemodynamic variablesBefore administration of the study medications (t0), and at 1 (t1), 3 (t2), and 10 (t3) minutes after the seizure ended.During perioperative period: Before administration of the study medications (t0), and at 1 (t1), 3 (t2), and 10 (t3) minutes after the seizure ended.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026